Use of Nanoparticle Paclitaxel (ABI-007) for the Prevention of In-Stent Restenosis
Clinical trial NCT00124943 · COMPLETED
Trial details
- NCT number
- NCT00124943
- Sponsor
- Celgene Corporation
- Status
- COMPLETED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2005-07-01
- Primary completion
- 2009-08-01
- Enrollment
- 112
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.